Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy of ODSH in Protein Losing Enteropathy Secondary to Single Ventricle Palliative Surgery
This study has been terminated.
( Extremely slow accural due to rarity of medical condition studied. )
Study NCT01161641   Information provided by ParinGenix

First Received on July 9, 2010.   Last Updated on May 8, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Intestinal Diseases
Protein-Losing Enteropathies
More general conditions related to this trial
Digestive System Diseases
Gastrointestinal Diseases
Interventions listed in this trial
ODSH at 0.125 mg/kg/h
ODSH at 0.375 mg/kg/h
ODSH at 0.250 mg/kg/h
Sponsors listed in this trial
ParinGenix


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services